Ensaio Clínico
NCT05271409). Recrutamento, Ativo
Meteoróide
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab As Monotherapy Or In Addition To Baseline Therapy In Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
Doença
Tipo de doença
MOGAD
Tipo de paciente
Adulto
Crianças
Inclusão / Exclusão
Métodos
privado
Membros envolvidos
Site de investigação de membro do ERN EYE
HCP: investigadores principais
Charité – Universitätsmedizin Berlin, Germany
Adress
Charitépl. 1
10117 Berlin
Germany
Clinica Oculistica – Ospedale Policlinico San Martino IRCCS, Genova, Italy
Adress
Viale Benedetto XV, 7
16132 Genova GE
Italy